Evaluation of the Structural, Physicochemical, and Biological Characteristics of SB11, as Lucentis(®) (Ranibizumab) Biosimilar

por Kim, Eunji, Han, Jihyeon, Chae, Yunjung, Park, Hyerim, Kim, Saerom, Kim, Seokkyun, Lee, Jungmin, Kim, Beom Chan
Publicado 2022

Antibody neutralization of cell-surface gC1qR/HABP1/SF2-p32 prevents lamellipodia formation and tumorigenesis

por Kim, Beom-Chan, Hwang, Hyun-Jung, An, Hyoung-Tae, Lee, Hyun, Park, Jun-Sub, Hong, Jin, Ko, Jesang, Kim, Chungho, Lee, Jae-Seon, Ko, Young-Gyu
Publicado 2016